Ultrasound or MRI to help prevent liver cancer deaths
Part of Cancer, Digestive system clinical trials.
This study compares ultrasound scans versus MRI scans to see which one better helps prevent deaths from liver cancer in people with cirrhosis. You may be assigned to one of the two imaging tests and follow-up visits to track whether liver cancer develops or is caught early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 18 to 75 years
- Have cirrhosis (scarred liver) confirmed by tests or signs of portal pressure (like varices/ascites/encephalopathy)
- Be at higher risk for liver cancer, such as current hepatitis C infection or a recent risk score indicating high risk
- Have not had liver cancer before, and there should not be current strong suspicion of liver cancer
- Be well enough to undergo scans and study visits (enough life expectancy, not in advanced liver failure)
- Be able to get MRI with contrast if you’re assigned to MRI (no gadolinium allergy, no MRI-incompatible devices, can tolerate the machine, and can fit within limits)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of scans to see which detects liver cancer better in people at high risk. You would receive either an MRI with contrast or an ultrasound every 6 months to monitor for liver cancer.
This study tests whether offering an ultrasound and a blood test (alpha-fetoprotein) every 6 months can help find liver cancer early in people with cirrhosis (scarred liver) caused by conditions other than hepatitis B or C. The goal is to reduce deaths from liver cancer in this group.
This study tests a new way to screen for liver cancer in people with chronic liver disease, especially those with cirrhosis or significant liver scarring. It uses blood tests and imaging to catch cancer early.
This study tests a digital (computer/phone-based) system to help track people with higher risk of liver cancer so cancers can be found earlier. It may help by guiding regular check-ins and making early diagnosis more efficient.
This study follows people with cirrhosis to see how best to detect liver cancer early. If you qualify, you may receive regular monitoring that could help find liver cancer sooner, when treatment is more likely to work.
This trial is testing a new way to screen for liver cancer in people with cirrhosis or chronic hepatitis B. It aims to find cancer earlier so it can be treated more effectively.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.